ADAR1 Capital Management’s Xilio Therapeutics XLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-40,000	Closed	-$29K	–	228
2025 Q1	$29K	Buy	+40,000	New	+$29K	0.01%	184
2024 Q3	–	Sell	-1,500	Closed	-$1.42K	–	319
2024 Q2	$1.42K	Buy	+1,500	New	+$1.42K	﹤0.01%	237